银屑病患者冠脉斑块特征及治疗后的改善:前瞻性观察研究
本研究对比银屑病患者、高脂血症患者及健康志愿者的冠脉斑块负荷与高危斑块 prevalence,发现银屑病患者非钙化斑块负荷及高危斑块均高于健康志愿者,且非钙化斑块负荷与较年长高脂血症患者相当;随访1年,银屑病严重程度改善与斑块负荷改善相关。
要点
- 银屑病患者非钙化冠脉斑块负荷及高危斑块 prevalence 高于健康志愿者。
- 银屑病患者非钙化斑块负荷与较年长高脂血症患者相当,高危斑块 prevalence 相似。
- 银屑病严重程度改善与1年时冠脉斑块负荷改善相关。
核心结论
- 银屑病患者非钙化冠脉斑块负荷及高危斑块 prevalence 高于健康志愿者,非钙化斑块负荷与较年长高脂血症患者相当。
- 银屑病严重程度改善与1年时总冠脉斑块负荷及非钙化斑块负荷改善相关。
研究设计与样本
- 前瞻性观察研究,纳入银屑病患者105例、符合NCEP-ATP III他汀治疗指征的高脂血症患者100例(约年长10岁)及无银屑病健康志愿者25例。
- 患者接受冠状动脉CT血管造影定量总冠脉斑块负荷、非钙化斑块负荷并识别高危斑块。
- 对前50例银屑病患者在治疗1年后再次扫描。
主要发现
- 银屑病患者较健康志愿者总冠脉斑块负荷升高(1.22±0.31 vs 1.04±0.22,P=0.001)。
- 银屑病患者较健康志愿者非钙化斑块负荷升高(1.18±0.33 vs 1.03±0.21,P=0.004)。
- 银屑病患者较健康志愿者高危斑块 prevalence 升高,超出传统危险因素(OR 6.0,95%CI 1.1-31.7,P=0.03)。
- 银屑病患者较高脂血症患者非钙化斑块负荷升高(1.18±0.33 vs 1.11±0.32,P=0.02),高危斑块 prevalence 相似(P=0.58)。
- 银屑病患者随访1年,银屑病严重程度改善与总冠脉斑块负荷改善相关(β=0.45,95%CI 0.23-0.67,P<0.001),与非钙化斑块负荷改善相关(β=0.53,95%CI 0.32-0.74,P<0.001),均超出传统危险因素。
关键数值与推荐
- 高危斑块定义为低衰减(<30 HU)、正性重构(>1.10)和点状钙化。
临床怎么用
- 对银屑病患者应关注亚临床冠脉粥样硬化负担,尤其是非钙化斑块和高危斑块。
- 控制银屑病皮肤炎症可能与1年时冠脉斑块负荷改善相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis, a chronic inflammatory disease associated with an accelerated risk of myocardial infarction, provides an ideal human model to study inflammatory atherogenesis in vivo. We hypothesized that the increased cardiovascular risk observed in psoriasis would be partially attributable to an elevated subclinical coronary artery disease burden composed of noncalcified plaques with high-risk features. However, inadequate efforts have been made to directly measure coronary artery disease in this vulnerable population. As such, we sought to compare total coronary plaque burden and noncalcified coronary plaque burden (NCB) and high-risk plaque (HRP) prevalence between patients with psoriasis (n=105), patients with hyperlipidemia eligible for statin therapy under National Cholesterol Education Program-Adult Treatment Panel III guidelines (n=100) who were ≈10 years older, and healthy volunteers without psoriasis (n=25). METHODS: Patients underwent coronary computed-tomography angiography for total coronary plaque burden and NCB quantification and HRP identification, defined as low attenuation (<30 hounsfield units), positive remodeling (>1.10), and spotty calcification. A consecutive sample of the first 50 patients with psoriasis was scanned again 1 year after therapy. RESULTS: Despite being younger and at lower traditional risk than patients with hyperlipidemia, patients with psoriasis had increased NCB (mean±SD: 1.18±0.33 versus 1.11±0.32, P=0.02) and similar HRP prevalence (P=0.58). Furthermore, compared to healthy volunteers, patients with psoriasis had increased total coronary plaque burden (1.22±0.31 versus 1.04±0.22, P=0.001), NCB (1.18±0.33 versus 1.03±0.21, P=0.004), and HRP prevalence beyond traditional risk (odds ratio, 6.0; 95% confidence interval, 1.1-31.7; P=0.03). Last, among patients with psoriasis followed for 1 year, improvement in psoriasis severity was associated with improvement in total coronary plaque burden (β=0.45, 0.23-0.67; P<0.001) and NCB (β=0.53, 0.32-0.74; P<0.001) beyond traditional risk factors. CONCLUSIONS: Patients with psoriasis had greater NCB and increased HRP prevalence than healthy volunteers. In addition, patients with psoriasis had elevated NCB and equivalent HRP prevalence as older patients with hyperlipidemia. Last, modulation of target organ inflammation (eg, skin) was associated with an improvement in NCB at 1 year, suggesting that control of remote sites of inflammation may translate into reduced coronary artery disease risk.
引用
- Lerman JB, Joshi AA, Chaturvedi A, et al. Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study. Circulation. 2017. PMID: 28483812. doi:10.1161/CIRCULATIONAHA.116.026859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。